![Tim Stover](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tim Stover
Nessuna posizione attualmente
Patrimonio netto: - $ in data 30/06/2024
Provenienza dei contatti di primo grado di Tim Stover
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Tim Stover tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
University of Kentucky | College/University | Undergraduate Degree | |
Immodulon Therapeutics Ltd.
![]() Immodulon Therapeutics Ltd. BiotechnologyHealth Technology Part of Lifexx SA, Immodulon Therapeutics Ltd. is a late-stage clinical biotechnology company based in Uxbridge, UK. Immodulon is developing a highly differentiated cancer immunotherapy approach that primes the patient’s own innate immune system with the aim to significantly enhance the efficacy of a broad range of anti-cancer therapies, including chemotherapy and checkpoint inhibitors. The British company is developing imm-101, a heat-killed mycobacterium obuense, as a broad-spectrum immunomodulatory agent with the potential to treat a range of difficult-to-treat tumors including those considered to be immunologically “ cold, ” such as pancreatic cancer. Immodulon's imm-101 based immunotherapy complements other cancer therapies, including immune checkpoint inhibitors and chemotherapy. The company is focused on developing safe and effective immunotherapy treatments. The company was founded in 2007 by Charles Akle, John L. Stanford. Gertjan Bartlema has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Celularity, Inc. (United States)
![]() Celularity, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Celularity, Inc. engages in biotechnology company. The firm focuses on the study of placenta. The company was founded in Robert Joseph Hariri Gordon and Peter H. Diamandis in 2016 and is headquartered in Florham Park, NJ. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
BIOSIG TECHNOLOGIES, INC. | Medical Specialties | Director/Board Member | |
NEXGEL, INC. | Chemicals: Specialty | Director/Board Member | |
Viralclear Pharmaceuticals, Inc.
![]() Viralclear Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology ViralClear Pharmaceuticals, Inc. manufactures anti-viral drug. The company is headquartered in Westport, CT. | Pharmaceuticals: Major | Chairman | |
Arthritis Foundation New Jersey Chapter | Director/Board Member | ||
Biond Biologics Ltd.
![]() Biond Biologics Ltd. Pharmaceuticals: MajorHealth Technology Biond Biologics Ltd. engages in drug discovery and development. It offers cell-internalizing antibody platform that will enable antibody-targeting of intra-cellular immune factors. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. The company was founded by Ori Shilo and Tehila Ben-Moshe and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
Israel Biotech Fund
![]() Israel Biotech Fund Investment ManagersFinance Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel. | Investment Managers | Consultant / Advisor | |
Genentech, Inc.
![]() Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Sales & Marketing | |
MedImmune LLC
![]() MedImmune LLC BiotechnologyHealth Technology MedImmune LLC develops medicines for the prevention and treatment of infectious diseases such as cancer and immune system disorders. It offers solutions in the areas of monoclonal antibodies and vaccines for infection, oncology, respiratory disease and inflammation, cardiovascular diseases, and neuroscience. The company was founded by Wayne T. Hockmeyer in 1988 and is headquartered in Gaithersburg, MD. | Biotechnology | Corporate Officer/Principal | |
AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
GlaxoSmithKline, Inc.
![]() GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Orgenesis Maryland, Inc.
![]() Orgenesis Maryland, Inc. Pharmaceuticals: MajorHealth Technology Part of Orgenesis, Inc., Orgenesis Maryland, Inc. develops a novel therapeutic for the treatment of diabetes. The company is based in Germantown, MD. | Pharmaceuticals: Major | Chief Executive Officer | |
Corvidia Therapeutics, Inc.
![]() Corvidia Therapeutics, Inc. BiotechnologyHealth Technology Corvidia Therapeutics, Inc. is a biotechnology company focusing on cardiovascular therapies. It develops treatments for atherosclerotic cardiovascular disease, inflammation in chronic kidney diseases, and high triglyceride-induced acute pancreatitis. The company was founded by Michael H. Davidson, Rahul Kakkar, Matt Devalaraja, and Ram Aiyar in 2015 and is headquartered in Waltham, MA. | Biotechnology | Director/Board Member | |
Archigen Biotech Ltd.
![]() Archigen Biotech Ltd. Pharmaceuticals: MajorHealth Technology Archigen Biotech Ltd. is a British company that develops, manufactures, and distributes biological pharmaceuticals. Archigen Biotech is based in Cambridge, UK. The joint venture company was founded in 2014. | Pharmaceuticals: Major | Director/Board Member | |
Fujifilm Kyowa Kirin Biologics Co., Ltd.
![]() Fujifilm Kyowa Kirin Biologics Co., Ltd. BiotechnologyHealth Technology Fujifilm Kyowa Kirin Biologics Co., Ltd. develops and produces biopharmaceutical products and drugs. The joint venture company is based in Tokyo, Japan. It was founded in 2012, and the CEO is Yoshifumi Torii. | Biotechnology | Director/Board Member | |
Harvard Business School | College/University | Masters Business Admin | |
Harvard College | College/University | Undergraduate Degree | |
AstraZeneca, Inc.
![]() AstraZeneca, Inc. BiotechnologyHealth Technology Part of AstraZeneca PLC, AstraZeneca, Inc. manufactures vaccines. | Biotechnology | Corporate Officer/Principal | |
IMMUNOCORE HOLDINGS PLC | Biotechnology | Chief Operating Officer | |
Bright Peak Therapeutics, Inc.
![]() Bright Peak Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Bright Peak Therapeutics AG, Bright Peak Therapeutics, Inc. develops immunotherapies for the treatment of cancer and autoimmune diseases. The company is based in San Diego, CA. The company was founded by Vijaya R. Pattabiraman, Jeffrey Bode. The CEO is Fredrik Wiklund. | Pharmaceuticals: Major | Director/Board Member | |
University of California, Berkeley | College/University | Doctorate Degree | |
New York University | College/University | Graduate Degree | |
Dana-Farber Cancer Institute, Inc.
![]() Dana-Farber Cancer Institute, Inc. Hospital/Nursing ManagementHealth Services Dana-Farber Cancer Institute, Inc. provides treatment to cancer patients and also researches new cancer diagnostics, treatments, and preventions. The firm's patients receive treatment through its cancer centers operated with Brigham and Women's Hospital, Children's Hospital Boston, Massachusetts General Hospital, and Beth Israel Deaconess Medical Center. The company was founded by Sidney Farber in 1947 and is headquartered in Boston, MA. | Hospital/Nursing Management | Corporate Officer/Principal | |
University of Utah | College/University | Undergraduate Degree | |
Nextpoint Therapeutics, Inc.
![]() Nextpoint Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nextpoint Therapeutics, Inc. is a biotech company based in Cambridge, MA. The company is advancing the field of immuno-oncology through its leading scientific work on the novel HHLA2 pathway. The company's innovative approach integrates foundational science with a defined clinical biomarker to deliver a new class of monotherapies for patients who will not benefit from PD-1/L1 inhibitors. Nextpoint Therapeutics has assembled a team of proven drug developers to build a broad strategic pipeline of first-in-class immunotherapies. Detlev Biniszkiewicz has been the CEO of the company since 2018. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Celgene Global Health | Chief Executive Officer | ||
BEYOND AIR, INC. | Medical Specialties | Director/Board Member | |
University of South Florida | College/University | Undergraduate Degree | |
International Castlemans Disease Organization | Director/Board Member | ||
EMD Serono, Inc.
![]() EMD Serono, Inc. Pharmaceuticals: MajorHealth Technology EMD Serono, Inc. operates as a biopharmaceutical firm. The firm develops recombinant prescription medicines. Its therapies include neurology and immunology, metabolic endocrinology, fertility, and oncology. The company was founded in 1971 and is headquartered in Rockland, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
IR BIOSCIENCES HOLDINGS, INC. | Biotechnology | Director/Board Member | |
SOLIGENIX, INC. | Pharmaceuticals: Major | Director/Board Member | |
Brown University | College/University | Graduate Degree | |
Yale University | College/University | Doctorate Degree | |
CELGENE | Biotechnology | Chief Tech/Sci/R&D Officer | |
Semorex, Inc. | Director/Board Member | ||
ImmuneRegen BioSciences, Inc.
![]() ImmuneRegen BioSciences, Inc. Miscellaneous Commercial ServicesCommercial Services ImmuneRegen BioSciences, Inc. researches and develops immunomodulation to improve pulmonary function and stimulating the human immune system. The company is headquartered in Scottsdale, AZ. | Miscellaneous Commercial Services | Director/Board Member | |
PTC THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Central New Jersey Council Boy Scouts of America
![]() Central New Jersey Council Boy Scouts of America Miscellaneous Commercial ServicesCommercial Services Central New Jersey Council Boy Scouts of America provides programs, events and opportunities of a lifetime that serve to shape the lives of young men and women in Central and Northern New Jersey. The company was founded in 1995 and is headquartered in Monmouth Junction, NJ. | Miscellaneous Commercial Services | Director/Board Member | |
CLARITAS PHARMACEUTICALS, INC. | Pharmaceuticals: Other | Director/Board Member | |
The Arthritis Foundation
![]() The Arthritis Foundation Miscellaneous Commercial ServicesCommercial Services Arthritis Foundation provides funds research, advocacy and support services for various kinds of arthritis and related diseases. It offers programs and services including aquatic programs, information about treatment breakthroughs, exercise tips for people with the disease and pain management information. Arthritis Foundation is located in Atlanta, GA. | Miscellaneous Commercial Services | Director/Board Member | |
PTC Corp. | Director/Board Member | ||
Harvard Medical School | College/University | Corporate Officer/Principal |
Statistiche
Distribuzione geografica
Stati Uniti | 43 |
Regno Unito | 4 |
Israele | 3 |
Canada | 2 |
Giappone | 2 |
Settori
Health Technology | 26 |
Consumer Services | 11 |
Commercial Services | 6 |
Process Industries | 3 |
Finance | 2 |
Posizioni
Director/Board Member | 29 |
Corporate Officer/Principal | 17 |
Independent Dir/Board Member | 8 |
Chief Tech/Sci/R&D Officer | 7 |
Undergraduate Degree | 5 |
Contatti più connessi
Insiders | |
---|---|
Jerome Zeldis | 38 |
John Trainer | 8 |
Leena Gandhi | 8 |
Scott Carmer | 7 |
Matthew Schiller | 5 |
- Borsa valori
- Insiders
- Tim Stover
- Connessioni Società